American Journal of Epidemiology Vol. 151, No. 10: 951-957
Copyright © 2000 by The Johns Hopkins University School of Hygiene and Public Health
other |
Antidepressant Medication Use and Breast Cancer Risk
1Division of Preventive Oncology, Cancer Care Ontario, Toronto, Ontario Canada
2Department of Public Health Sciences, University of Toronto Toronto, Ontario, Canada
3Faculty of Nursing, University of Toronto, Toronto, Ontario Canada
4Department of Psychiatry, University of Toronto, Toronto, Ontario Canada
Experimental and epidemiologic studies suggest that antidepressant medication use may be associated with breast cancer risk. This hypothesis was investigated using a population-based case-control study; cases diagnosed in 1995–1996 were identified using the Ontario Cancer Registry, and controls were randomly sampled from an Ontario Ministry of Finance database. Data were collected using a self-administered questionnaire, and multivariate logistic regression was used to estimate odds ratios and 95% confidence intervals. Adjusted odds ratio estimates ranged from 0.7 to 0.8 and were not statistically significant for "ever" use of antidipressants, tricyclics, and selective serotonin reuptake inhibitors. Compared with no antidepressant use, use of tricyclic antidepressants for greater than 2 years‘ duration was associated with an elevated risk of breast cancer (odds ratio (OR) = 2.1, 95% confidence interval (Cl): 0.9, 5.0). Of the six most commonly reported antidepressant medications, only paroxetine use was associated with an increase in breast cancer risk (OR = 7.2, 95% Cl: 0.9, 58.3). Results from this study do not support the hypothesis that "ever" use of any antidepressant medications is associated with breast cancer risk. Use of tricyclic medications for greater than 2 years, however, may be associated with a twofold elevation, and use of paroxetine may be associated with a substantial increase in breast cancer risk. Am J Epidemiol 2000; 151:951-7.
antidepressive agents; breast neoplasms; case-control studies; pharmacoepidemiology; risk factors
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Stebbing, T. Powles, S. Mandalia, M. Nelson, B. Gazzard, and M. Bower Use of Antidepressants and Risk of Cancer in Individuals Infected With HIV J. Clin. Oncol., May 10, 2008; 26(14): 2305 - 2310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Marshall, W. Sakr, D. Wood, D. Berry, C. Tangen, F. Parker, I. Thompson, S. M. Lippman, R. Lieberman, D. Alberts, et al. Design and Progress of a Trial of Selenium to Prevent Prostate Cancer among Men with High-Grade Prostatic Intraepithelial Neoplasia. Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1479 - 1484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Steingart, M. Cotterchio, N. Kreiger, and M. Sloan Antidepressant medication use and breast cancer risk: a case-control study Int. J. Epidemiol., December 1, 2003; 32(6): 961 - 966. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zuess An Integrative Approach to Depression: Part 2--Assessment and Treatment Complementary Health Practice Review, April 1, 2003; 8(2): 99 - 115. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Leffondre, M. Abrahamowicz, J. Siemiatycki, and B. Rachet Modeling Smoking History: A Comparison of Different Approaches Am. J. Epidemiol., November 1, 2002; 156(9): 813 - 823. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Lawlor, K. L. Beebe, R. Zaninelli, B. Trock, M. Cotterchio, and N. Kreiger RE: "ANTIDEPRESSANT MEDICATION USE AND BREAST CANCER RISK" Am. J. Epidemiol., December 1, 2000; 152(11): 1104 - 1016. [Full Text] [PDF]
|
|